Skip to content
Screener

Abbott ABT Amortization of capitalized software and acquired intangible assets

Amortization of capitalized software and acquired intangible assets at other companies

LivaNova logo
LivaNovaLIVN
$6.66M+50.0%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Boston Scientific logo
Boston ScientificBSX
AngioDynamics logo
AngioDynamicsANGO
Medtronic logo
MedtronicMDT
BellRing Brands logo
BellRing BrandsBRBR

Other financials

Income statement

See full
Revenue$12.6B+13.0%
Gross profit$7.3B+15.6%
Operating income$1.7B-17.5%
Net income$928.0M-47.8%
EPS (diluted)$0.53-47.5%

Balance sheet

See full
Cash & equivalents$5.1B-26.6%
Total debt$32.6B+143%
Total equity$51.1B+1.1%
Total assets$109.22B+30.0%

Cash flow

See full
Operating cash flow$2.5B+21.5%
CapEx$497.0M-1.0%
Free cash flow$2.0B+28.9%

Valuation

See full
Market cap$187.95B-17.8%
Enterprise value$215.46B-8.4%
P/E34.7×+18.3×
P/S-1.3×

Profitability

See full
Gross margin56.6%+0.6pp
Operating margin15.8%-1.7pp
Net margin11.6%-20.8pp
FCF margin16.8%+1.1pp

Returns & leverage

See full
Return on equity10.7%-20.4pp
Debt / equity0.6×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The source filing: Abbott’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050134
Line itemThree Months Ended / June 30 / 2026Three Months Ended / June 30 / 2025Six Months Ended / June 30 / 2026Six Months Ended / June 30 / 2025
Net sales$12,593$11,142$23,757$21,500
Cost of products sold, excluding amortization of intangible assets5,3254,85410,2159,322
Amortization of intangible assets6584201,080840
Research and development8927251,6591,441
Selling, general, and administrative4,0253,0917,7656,152
Total operating cost and expenses10,9009,09020,71917,755
Operating earnings1,6932,0523,0383,745
Interest expense351121525252

Item 1. Financial Statements and Supplementary Data

FAQ

What is Abbott's amortization of capitalized software and acquired intangible assets?
Abbott (ABT) reported amortization of capitalized software and acquired intangible assets of $658M in Q2 2026.
How has Abbott's amortization of capitalized software and acquired intangible assets changed year-over-year?
Abbott's amortization of capitalized software and acquired intangible assets increased by 56.7% year-over-year, from $420M to $658M.
What is the long-term trend for Abbott's amortization of capitalized software and acquired intangible assets?
Over 4 years (2021 to 2025), Abbott's amortization of capitalized software and acquired intangible assets has grown at a -4.8% compound annual growth rate (CAGR), from $2.05B to $1.68B.

Ask your AI about Abbott's amortization of capitalized software and acquired intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude